ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

2,38
-0,03
(-1,24%)
Geschlossen 08 Februar 10:00PM
2,40
0,02
(0,84%)
Nach Börsenschluss: 11:22PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
2,40
Gebot
-
Fragen
-
Volumen
2.335.143
2,29 Tagesbereich 2,42
1,57 52-Wochen-Bereich 4,1598
Marktkapitalisierung
Handelsende
2,41
Handelsbeginn
2,41
Letzte Trade
100
@
2.4
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 5.477.263
VWAP
2,3456
Durchschnittliches Volumen (3 Mio.)
2.542.442
Ausgegebene Aktien
336.566.525
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-10,57
Gewinn pro Aktie (EPS)
-0,23
Erlöse
-
Nettogewinn
-75,8M

Über Panacea Acquisition Corp

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the New York Börse with ticker NUVB. The last closing price for Panacea Acquisition was US$2,41. Over the last year, Panacea Acquisition shares have traded in a share price range of US$ 1,57 to US$ 4,1598.

Panacea Acquisition currently has 336.566.525 shares in issue. The market capitalisation of Panacea Acquisition is US$811,13 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -10.57.

NUVB Neueste Nachrichten

Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for...

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief...

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

Taletrectinib will be marketed in China by Innovent Biologics Approval is based on the pivotal Phase 2 TRUST-I study, demonstrating taletrectinib's durable responses and prolonged...

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

New Drug Application (NDA) is based on pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies of taletrectinib that demonstrated durable responses and prolonged progression-free...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 20...

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.010.4184100418412.392.49072.22519444372.35266348CS
4-0.49-16.9550173012.892.992.22524437192.5302566CS
12-0.44-15.49295774652.843.4552.22525424422.7071486CS
26-0.64-21.05263157893.043.455220325812.6875494CS
520.7646.34146341461.644.15981.5717802812.82751462CS
156-3.39-58.54922279795.796.050.9511400672.66248366CS
260-7.6-761015.230.9510762844.15815969CS

NUVB - Frequently Asked Questions (FAQ)

What is the current Panacea Acquisition share price?
The current share price of Panacea Acquisition is US$ 2,40
How many Panacea Acquisition shares are in issue?
Panacea Acquisition has 336.566.525 shares in issue
What is the market cap of Panacea Acquisition?
The market capitalisation of Panacea Acquisition is USD 811,13M
What is the 1 year trading range for Panacea Acquisition share price?
Panacea Acquisition has traded in the range of US$ 1,57 to US$ 4,1598 during the past year
What is the PE ratio of Panacea Acquisition?
The price to earnings ratio of Panacea Acquisition is -10,57
What is the reporting currency for Panacea Acquisition?
Panacea Acquisition reports financial results in USD
What is the latest annual profit for Panacea Acquisition?
The latest annual profit of Panacea Acquisition is USD -75,8M
What is the registered address of Panacea Acquisition?
The registered address for Panacea Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Panacea Acquisition website address?
The website address for Panacea Acquisition is ecor1cap.com
Which industry sector does Panacea Acquisition operate in?
Panacea Acquisition operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DOCSDoximity Inc
US$ 79,21
(35,96%)
10,26M
BBAIBigBear ai Holdings Inc
US$ 8,595
(26,96%)
231,27M
SWISolarWinds Corporation
US$ 18,331
(21,96%)
10,07M
ESEESCO Technologies Inc
US$ 158,57
(19,75%)
331,73k
PINSPinterest Inc
US$ 40,00
(19,08%)
51,46M
BILLBILL Holdings Inc
US$ 62,13
(-35,52%)
28,46M
ELFe l f Beauty Inc
US$ 71,13
(-19,62%)
23,55M
GHMGraham Corp
US$ 39,69
(-16,05%)
622,53k
MUXMcEwen Mining Inc
US$ 7,37
(-14,80%)
10,33M
SKXSkechers USA
US$ 66,03
(-12,68%)
10,54M
BBAIBigBear ai Holdings Inc
US$ 8,595
(26,96%)
231,27M
FFord Motor Company
US$ 9,24
(-0,22%)
140,89M
UBERUber Technologies Inc
US$ 74,60
(6,59%)
81,99M
BBDBanco Bradesco SA
US$ 2,105
(-5,61%)
79,66M
QBTSD Wave Quantum Inc
US$ 5,8097
(-3,01%)
59,28M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock